IBM Retirement Fund Sells 196 Shares of CME Group Inc (CME)
IBM Retirement Fund lowered its position in shares of CME Group Inc (NASDAQ:CME) by 3.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,372 shares of the financial services provider’s stock after selling 196 shares during the period. IBM Retirement Fund’s holdings in CME Group were worth $1,011,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. increased its stake in CME Group by 8.2% during the 4th quarter. BlackRock Inc. now owns 24,250,752 shares of the financial services provider’s stock worth $4,562,052,000 after acquiring an additional 1,828,640 shares during the period. Oregon Public Employees Retirement Fund increased its stake in CME Group by 18,502.9% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 16,220,459 shares of the financial services provider’s stock worth $86,000 after acquiring an additional 16,133,266 shares during the period. Capital International Investors increased its stake in CME Group by 18.3% during the 3rd quarter. Capital International Investors now owns 15,425,378 shares of the financial services provider’s stock worth $2,625,554,000 after acquiring an additional 2,383,280 shares during the period. Capital Research Global Investors increased its stake in CME Group by 107.8% during the 3rd quarter. Capital Research Global Investors now owns 10,906,683 shares of the financial services provider’s stock worth $1,856,427,000 after acquiring an additional 5,658,108 shares during the period. Finally, Edgewood Management LLC increased its stake in CME Group by 9.5% during the 3rd quarter. Edgewood Management LLC now owns 8,582,518 shares of the financial services provider’s stock worth $1,460,830,000 after acquiring an additional 742,067 shares during the period. Institutional investors own 88.49% of the company’s stock.
Shares of CME stock opened at $170.14 on Friday. The firm has a market capitalization of $60.88 billion, a price-to-earnings ratio of 24.95, a price-to-earnings-growth ratio of 2.15 and a beta of 0.31. CME Group Inc has a fifty-two week low of $153.90 and a fifty-two week high of $197.08. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.01 and a current ratio of 1.01.
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 25th. Shareholders of record on Friday, March 8th will be issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date of this dividend is Thursday, March 7th. This is an increase from CME Group’s previous quarterly dividend of $0.70. CME Group’s dividend payout ratio (DPR) is currently 43.99%.
In related news, CFO John W. Pietrowicz sold 17,960 shares of the firm’s stock in a transaction on Wednesday, January 2nd. The stock was sold at an average price of $186.92, for a total transaction of $3,357,083.20. Following the sale, the chief financial officer now owns 44,780 shares of the company’s stock, valued at approximately $8,370,277.60. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jeffrey M. Bernacchi sold 10,087 shares of the firm’s stock in a transaction on Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total value of $1,794,880.78. Following the sale, the director now directly owns 42,004 shares in the company, valued at approximately $7,474,191.76. The disclosure for this sale can be found here. In the last ninety days, insiders sold 32,609 shares of company stock worth $5,984,391. Company insiders own 0.43% of the company’s stock.
A number of equities analysts have commented on CME shares. Berenberg Bank upgraded CME Group from a “hold” rating to a “buy” rating and set a $220.00 price objective on the stock in a research note on Tuesday, November 20th. BidaskClub lowered CME Group from a “hold” rating to a “sell” rating in a research note on Wednesday, February 20th. Bank of America restated a “neutral” rating and set a $191.00 price objective (down previously from $200.00) on shares of CME Group in a research note on Friday, January 11th. They noted that the move was a valuation call. Deutsche Bank lowered their price objective on CME Group from $220.00 to $214.00 and set a “buy” rating on the stock in a research note on Friday. Finally, Atlantic Securities assumed coverage on CME Group in a research note on Wednesday, November 28th. They set a “neutral” rating and a $200.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $194.00.
COPYRIGHT VIOLATION NOTICE: “IBM Retirement Fund Sells 196 Shares of CME Group Inc (CME)” was first posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.dailypolitical.com/2019/03/17/ibm-retirement-fund-sells-196-shares-of-cme-group-inc-cme.html.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Featured Story: How much can an individual set aside as a catch-up contribution?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.